Chapter 10. Clinical Trials

  1. Peter M. Fayers1,2 and
  2. David Machin3,4,5

Published Online: 27 APR 2007

DOI: 10.1002/9780470024522.ch10

Quality of Life: The Assessment, Analysis and Interpretation of Patient-Reported Outcomes, Second edition

Quality of Life: The Assessment, Analysis and Interpretation of Patient-Reported Outcomes, Second edition

How to Cite

Fayers, P. M. and Machin, D. (2007) Clinical Trials, in Quality of Life: The Assessment, Analysis and Interpretation of Patient-Reported Outcomes, Second edition, John Wiley & Sons, Ltd, Chichester, UK. doi: 10.1002/9780470024522.ch10

Author Information

  1. 1

    University of Aberdeen Medical School, Scotland, UK

  2. 2

    Norwegian University of Science and Technology (NTNU), Trondheim, Norway

  3. 3

    Division of Clinical Trials and Epidemiological Sciences, National Cancer Centre, Singapore

  4. 4

    School of Health and Related Research, University of Sheffield, England

  5. 5

    United Kingdom Children's Cancer Study Group (UKCCSG), University of Leicester, England

Publication History

  1. Published Online: 27 APR 2007
  2. Published Print: 2 MAR 2007

ISBN Information

Print ISBN: 9780470024508

Online ISBN: 9780470024522

SEARCH

Keywords:

  • QoL in clinical trials;
  • measuring compliance;
  • administering quality-of-life assessment;
  • role of QoL assessment;
  • good compliance in QoL data collection;
  • recommendations in writing protocols;
  • assessment during therapy;
  • QoL forms influencing therapy

Summary

This chapter contains sections titled:

  • Introduction

  • Basic design issues

  • Compliance

  • Administering a quality-of-life assessment

  • Recommendations for writing protocols

  • Standard operating procedures

  • Summary and checklist